-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We lower our 12-month target by $5 to $35, based on a 2027 P/E of 7.0x, a justified discount to TAP's five-year average forward P/E of 11.4x. We raise our adjusted EPS estimates by $0.20 to $4.90 for '26 and by $0.10 to $5.10 for '27. Following TAP's Q1 earnings release, we are lowering our price target and maintaining a Sell opinion on the shares. TAP posted Q1 adjusted EPS of $0.62 vs. $0.50 (+24%), well ahead of the $0.36 consensus. The beat was due to stronger-than-expected sales and margins, as net sales rose 2.0% to $2.35B ($25 above consensus) on a 2.9% drop in financial volume and gross margin expanded 130 bps to 38.2% (350 bps ahead of consensus). While TAP's Q1 earnings were well ahead of expectations, the fact that it didn't increase full-year guidance raises concerns that the balance of the year will be weaker than previously anticipated, with positive foreign exchange impacts likely to be less favorable than in Q1. We struggle to identify a catalyst and see the demand environment remaining challenging.